The SRC inhibitor dasatinib induces stem cell-like properties in head and neck cancer cells that are effectively counteracted by the mithralog EC-8042

  1. Hermida-Prado, F.
  2. Villaronga, M.Á.
  3. Granda-Díaz, R.
  4. Del-Río-Ibisate, N.
  5. Santos, L.
  6. Hermosilla, M.A.
  7. Oro, P.
  8. Allonca, E.
  9. Agorreta, J.
  10. Garmendia, I.
  11. Tornín, J.
  12. Perez-Escuredo, J.
  13. Fuente, R.
  14. Montuenga, L.M.
  15. Morís, F.
  16. Rodrigo, J.P.
  17. Rodríguez, R.
  18. García-Pedrero, J.M.
Journal:
Journal of Clinical Medicine

ISSN: 2077-0383

Year of publication: 2019

Volume: 8

Issue: 8

Type: Article

DOI: 10.3390/JCM8081157 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus